About the Author: Miranda A. Farage is a Research Fellow in the Clinical Sciences Innovation at The Procter and Gamble Company, Cincinnati, Ohio. Dr. Farage leads research on genital health, dermatological testing and claims, methods development, sensitive skin, physiology, toxicology, women's health, quality of life, and related fields. She is the author of more than 190 manuscripts in peer-reviewed journals. She is also the co-editor of several books and has co-authored medical textbooks on women's health, aging skin and consumers, cosmeceutical sciences, and dermatotoxicology. Dr. Farage is on the editorial board of several scientific journals. Dr. Farage received a PhD in Medical Sciences from the University of Illinois, Urbana-Champaign.
Kenneth W. Miller is the Associate Director for Global Product Stewardship in the Feminine Care business unit at The Procter and Gamble Company. Dr. Miller is responsible for the strategic development and execution of research and testing in the areas of dermatotoxicology, clinical safety and efficacy studies, post-market surveillance studies, epidemiology studies, environmental studies (biodegradation, solid waste disposal, aquatic and terrestrial toxicology, and global waste disposal infrastructure), standard microbiological testing, and microbiological methods development research (including molecular microbiology techniques). He also has responsibility for a team conducting microbiological and clinical research in toxic shock syndrome, superantigens, and vaginal microbial ecology. Dr. Miller has published over fifty manuscripts in the area of toxicology in peer-reviewed journals plus numerous abstracts, book chapters, and presentations at meetings of scientific societies. Dr. Miller is a member of several scientific and professional societies.
Nancy Fugate Woods, PhD, RN, FAAN, is Professor and Dean Emeritus at the University of Washington School of Nursing. Dr. Woods has led a sustained program of research in the field of women's health. Her collaborative, interdisciplinary research has resulted in an improved understanding of women's experiences of menstrual cycle symptoms as well as the menopausal transition, including endocrine, social, personal, and genetic factors influencing symptoms and women's approaches to symptom management. In 1989, Dr. Woods and her colleagues, including Dr. Joan Shaver, established the first NIH-funded Center for Women's Health Research at the University of Washington School of Nursing and established the Seattle Midlife Women's Health Study, a longitudinal study of women during the menopausal transition and early postmenopause. Dr. Woods is an investigator for the Women's Health Initiative Study and for the MsFLASH study of symptom management approaches for hot flashes and related symptoms. Her honors include election to the Institute of Medicine of the National Academies and to the American Academy of Nursing.
Howard I. Maibach is Professor of Dermatology at the University of California at San Francisco School of Medicine. He is the author of over 1700 papers in dermatology, toxicology, pharmacology, physiology, and related fields and the co-editor of several books, including Cosmeceuticals, Cutaneous Infection and Therapy, Cutaneous Infestations and Insect Bites, Neonatal Skin, Percutaneous Absorption, 3rd edition, and Psoriasis, 3rd edition. Dr. Maibach received his MD from Tulane University.
